169 related articles for article (PubMed ID: 15567030)
1. Adaptability costs in immune escape variants of vesicular stomatitis virus.
Novella IS; Gilbertson DL; Borrego B; Domingo E; Holland JJ
Virus Res; 2005 Jan; 107(1):27-34. PubMed ID: 15567030
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of fitness loss and fitness recovery in vesicular stomatitis virus.
Novella IS; Ebendick-Corpus BE
J Mol Biol; 2004 Oct; 342(5):1423-30. PubMed ID: 15364571
[TBL] [Abstract][Full Text] [Related]
3. Antigenic determinants of vesicular stomatitis virus: analysis with antigenic variants.
Lefrancois L; Lyles DS
J Immunol; 1983 Jan; 130(1):394-8. PubMed ID: 6183358
[TBL] [Abstract][Full Text] [Related]
4. Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells.
Novella IS; Hershey CL; Escarmis C; Domingo E; Holland JJ
J Mol Biol; 1999 Apr; 287(3):459-65. PubMed ID: 10092452
[TBL] [Abstract][Full Text] [Related]
5. Mode of selection and experimental evolution of antiviral drugs resistance in vesicular stomatitis virus.
Cuevas JM; Sanjuán R; Moya A; Elena SF
Infect Genet Evol; 2005 Jan; 5(1):55-65. PubMed ID: 15567139
[TBL] [Abstract][Full Text] [Related]
6. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
Martinez I; Barrera JC; Rodriguez LL; Wertz GW
Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
[TBL] [Abstract][Full Text] [Related]
7. Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection.
Vandepol SB; Holland JJ
J Gen Virol; 1986 Mar; 67 ( Pt 3)():441-51. PubMed ID: 3005478
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic mixing between vesicular stomatitis and Uukuniemi viruses.
Dragúnová J; Kozuch O; Gresíková M
Acta Virol; 1986 Nov; 30(6):512-4. PubMed ID: 2881472
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.
Kuate S; Stahl-Hennig C; Stoiber H; Nchinda G; Floto A; Franz M; Sauermann U; Bredl S; Deml L; Ignatius R; Norley S; Racz P; Tenner-Racz K; Steinman RM; Wagner R; Uberla K
Virology; 2006 Jul; 351(1):133-44. PubMed ID: 16616946
[TBL] [Abstract][Full Text] [Related]
10. Using G-deleted vesicular stomatitis virus to probe the innate anti-viral response.
Lai F; Kazdhan N; Lichty BD
J Virol Methods; 2008 Nov; 153(2):276-9. PubMed ID: 18692525
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice.
Zhang M; Ge J; Li X; Chen W; Wang X; Wen Z; Bu Z
Virol J; 2016 Feb; 13():31. PubMed ID: 26911572
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of vesicular stomatitis virus through inhibition of membrane fusion by chemical modification of the viral glycoprotein.
Stauffer F; De Miranda J; Schechter MC; Carneiro FA; Salgado LT; Machado GF; Da Poian AT
Antiviral Res; 2007 Jan; 73(1):31-9. PubMed ID: 16934341
[TBL] [Abstract][Full Text] [Related]
13. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA
J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
[TBL] [Abstract][Full Text] [Related]
14. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice.
Steinhoff U; Müller U; Schertler A; Hengartner H; Aguet M; Zinkernagel RM
J Virol; 1995 Apr; 69(4):2153-8. PubMed ID: 7884863
[TBL] [Abstract][Full Text] [Related]
15. IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors.
Klas SD; Lavine CL; Whitt MA; Miller MA
Vaccine; 2006 Feb; 24(9):1451-61. PubMed ID: 16310294
[TBL] [Abstract][Full Text] [Related]
16. Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus.
Ohishi M; Shioda T; Sakuragi J
Virology; 2007 May; 362(1):131-8. PubMed ID: 17258261
[TBL] [Abstract][Full Text] [Related]
17. Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps.
Ternette N; Stefanou D; Kuate S; Uberla K; Grunwald T
Virol J; 2007 Jun; 4():51. PubMed ID: 17550613
[TBL] [Abstract][Full Text] [Related]
18. Folimycin (concanamycin A), an inhibitor of V-type H(+)-ATPase, blocks cell-surface expression of virus-envelope glycoproteins.
Muroi M; Takasu A; Yamasaki M; Takatsuki A
Biochem Biophys Res Commun; 1993 Jun; 193(3):999-1005. PubMed ID: 8391816
[TBL] [Abstract][Full Text] [Related]
19. Generating vesicular stomatitis virus pseudotype bearing the severe acute respiratory syndrome coronavirus spike envelope glycoprotein for rapid and safe neutralization test or cell-entry assay.
Ge J; Wen Z; Wang X; Hu S; Liu Y; Kong X; Chen H; Bu Z
Ann N Y Acad Sci; 2006 Oct; 1081(1):246-8. PubMed ID: 17135519
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent gene transduction using gammaretroviral and lentiviral vectors pseudotyped with chimeric vesicular stomatitis virus glycoprotein.
Kameyama Y; Kawabe Y; Ito A; Kamihira M
J Virol Methods; 2008 Oct; 153(1):49-54. PubMed ID: 18606189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
